Research Studies
Clinical Trials
| Trial | PI/Additional Investigators | ClinicalTrials.gov Identifier |
|---|---|---|
| A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) (ANDECAL) | Edward Hsiao | |
| FALKON: Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral IPN60130 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). | Edward Hsiao | NCT05039515 |
| A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease | Chienying Liu | NCT05907668 |
| Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtylast) | Chienying Liu | NCT04490915 |
| Performance evaluation of the software medical device to detect the thyrotoxic state in patients with hyperthyroidism |
Umesh Masharani | NCT07017907 |
| D-Thio: Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing | Jen Perkins | |
| A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP) (FOPal) | Roger Long | NCT06089616 |
Investigator-Initiated Studies
| Trial | PI/Additional Investigators |
|---|---|
| Human Biospecimen Tissue Bank for the Study of Molecular Mechanisms of Hormonal Disorders (Endocrine Biobank) | Endocrine Division-wide |
| The Gut Microbiome in Human Endocrine diseases | Edward Hsiao |
| The UCSF Biospecimens and Skeletal Tissues for Rare and Orphan Disease Genetics (BSTROnG Biobank) | Edward Hsiao, Kelly Wentworth |
| New onset type 1 diabetes study | Mark Anderson, Zoe Quandt |
| Autoimmune polyendocrine syndrome 1 (APS1) study | Mark Anderson, Zoe Quandt |
| Atypical Diabetes study (in collaboration with U Chicago) | Mark Anderson, Zoe Quandt |
| Immune Checkpoint Inhibitor study | Mark Anderson, Zoe Quandt |
| Inflammation, Diabetes, Ethnicity and Obesity (IDEO) Cohort(NCT03022682) | Diana Alba, Suneil Koliwad |
| Immunologic and fat-associated predictors of insulin resistance in treated HIV | Suneil Koliwad, Peter Hunt, Diana Alba |
| Development of an Obesity and Immune-Mediated Disease Pipeline (IMMUNE-MET) (Not open for enrollment at this time) | Diana Alba |
| Risk factors for poor muscle health in older women using GLP-1 RA medications for weight loss and osteoarthritis management | Kristine Godziuk |